|
|
||||||||
Departments of Medicine and Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, and Nashville Veterans Affairs Medical Center, Nashville, Tennessee 37232
| |
ABSTRACT |
|---|
|
|
|---|
The aim of this study was to
determine whether a bout of morning exercise (EXE1) can
alter neuroendocrine and metabolic responses to subsequent afternoon
exercise (EXE2) and whether these changes follow a
gender-specific pattern. Sixteen healthy volunteers (8 men and 8 women,
age 27 ± 1 yr, body mass index 23 ± 1 kg/m2,
maximal O2 uptake 31 ± 2 ml · kg
1 · min
1) were
studied after an overnight fast. EXE1 and EXE2
each consisted of 90 min of cycling on a stationary bike at 48 ± 2% of maximal O2 uptake separated by 3 h. To avoid
the confounding effects of hypoglycemia and glycogen depletion,
carbohydrate (1.5 g/kg body wt po) was given after EXE1,
and plasma glucose was maintained at euglycemia during both episodes of
exercise by a modification of the glucose-clamp technique. Basal
insulin levels (7 ± 1 µU/ml) and exercise-induced insulin
decreases (
3 µU/ml) were similar during EXE1 and
EXE2. Plasma glucose was 5.2 ± 0.1 and 5.2 ± 0.1 mmol/l during EXE1 and EXE2, respectively.
The glucose infusion rate needed to maintain euglycemia during the last
30 min of exercise was increased during EXE2 compared with
EXE1 (32 ± 4 vs. 7 ± 2 µmol · kg
1 · min
1).
Although this increased need for exogenous glucose was similar in men
and women, gender differences in counterregulatory responses were
significant. Compared with EXE1, epinephrine,
norepinephrine, growth hormone, pancreatic polypeptide, and cortisol
responses were blunted during EXE2 in men, but
neuroendocrine responses were preserved or increased in women. In
summary, morning exercise significantly impaired the body's ability to
maintain euglycemia during later exercise of similar intensity and
duration. We conclude that antecedent exercise can significantly
modify, in a gender-specific fashion, metabolic and neuroendocrine
responses to subsequent exercise.
glucose clamp; epinephrine; glucagon
| |
INTRODUCTION |
|---|
|
|
|---|
DURING EXERCISE, a complex pattern of neuroendocrine and autonomic nervous system (ANS) counterregulatory responses protects against the occurrence of hypoglycemia (5, 12, 20). These mechanisms effectively maintain euglycemia in healthy individuals over a broad range of exercise intensities and begin to fail only when exercise is performed for a prolonged period of time (19, 35). Although the counterregulatory responses to a single episode of exercise have been investigated extensively (8, 22-24), only incomplete and conflicting information exists regarding the effects of a prior bout of exercise on the counterregulatory responses to subsequent exercise performed later during the same day. Consequently, increased or unchanged neuroendocrine responses have been reported during a second bout of same-day exercise (9, 29, 30, 33, 34). Furthermore, in the majority of the above-mentioned studies, only a limited number of neuroendocrine responses were measured. More importantly, in no study utilizing a multiple exercise protocol were attempts made to compensate for the decline in blood glucose that occurs during exercise or to replenish glycogen stores that were depleted during earlier exercise bouts. Blood glucose falls during submaximal exercise, the magnitude of the drop being directly related to the absolute intensity of the work performed and the duration of the exercise bout (19). The fall in blood glucose, however, is greater during successive bouts of exercise, even if duration and workload are identical (29). Exercise performed during hypoglycemic conditions elicits counterregulatory responses that are greater than those induced by exercise per se (19). Therefore, quantitative comparative assessments of neuroendocrine responses during similar episodes of exercise could be confounded by the presence of hypoglycemia.
Gender differences in counterregulatory responses have been reported after a single bout of exercise, although with somewhat conflicting conclusions (15, 38). Furthermore, after antecedent stress (hypoglycemia), healthy women display less blunting of counterregulatory responses to subsequent hypoglycemia than do men (17). Hypoglycemia and exercise have many qualitative similarities in the pattern of counterregulatory responses they generate. It is unknown, however, whether prior exercise would induce sexually dimorphic alterations in counterregulatory responses to later bouts of exercise.
We therefore designed the present study with the aims of determining
1) whether an earlier bout of exercise may alter the neuroendocrine and ANS responses to a second, equivalent bout of
same-day exercise and 2) whether any alterations in
counterregulatory responses induced during the later bout of exercise
would follow a gender-specific pattern. We hypothesized that if
subjects were maintained strictly euglycemic and glycogen stores were
replenished between exercise bouts, then counterregulatory responses
would be blunted by prior exercise, with a proportionally greater
reduction in men than in women. To test this hypothesis, we studied 16 healthy subjects of both genders who performed two 90-min submaximal
[~50% of maximal O2 uptake
(
O2 max)] cycle ergometer tests, separated by a 3-h interval. An integrative assessment of metabolic and
neuroendocrine responses was performed during both episodes of
exercise, so that a comparison of key counterregulatory responses could
be determined.
| |
RESEARCH DESIGN AND METHODS |
|---|
|
|
|---|
Subjects. We studied 16 healthy volunteers, 8 men and 8 women, age 27 ± 1 yr, body weight 74 ± 4 kg (83 ± 4 and 62 ± 2 kg for men and women, respectively), body mass index 23 ± 1 kg/m2 (24 ± 41 and 22 ± 1 kg/m2 for men and women, respectively), and glycosylated hemoglobin (HbA1c) 5.3 ± 0.1% (normal range 4.0-6.5%). None of the subjects were taking medications, nor did any of the subjects have a family history of diabetes. Each subject had a normal blood count, plasma electrolytes, and liver and renal function. All gave written informed consent. Studies were approved by the Vanderbilt University Human Subjects Institutional Review Board. The subjects were asked to avoid any exercise and consume their usual weight-maintaining diet for 3 days before each study. Female subjects were studied during the midfollicular phase of their menstrual cycle. Each subject was admitted to the Vanderbilt Clinical Research Center at 5 PM on the evening before an experiment. All subjects were studied after an overnight 10-h fast.
Experimental design.
At least 2 wk before the initial study, subjects performed an
incremental work test on a stationary cycle ergometer to determine
O2 max and anaerobic threshold (AT)
(36). Airflow and O2 and CO2
concentrations in inspired and expired air were measured by a
computerized open-circuit indirect calorimetry cart (Medical Graphics
CPX-D) with a mouthpiece-and-nose clip system. AT was determined by the
V-slope method (4). Experimental work rate was established
by calculating 80% AT. The AT was detected at 59 ± 3%
O2 max, and 80% of O2
uptake at AT corresponded to 47 ± 2% of the subject's
O2 max. This workload was chosen
because it is close enough to the AT to produce a physically challenging stress (i.e., large experimental signal) but is sustainable for a prolonged period of time. Subjects ranged from sedentary to
regularly exercising, although not actively participating in competitive sports. Mean
O2 max for the
group was 31 ± 2 ml · kg
1 · min
1 (range
21-43
ml · kg
1 · min
1).
Experimental procedures. On the morning of the study day, after an overnight fast, two intravenous cannulas were inserted under 1% lidocaine local anesthesia. One cannula was placed in a retrograde fashion into a vein on the back of the hand. This hand was placed in a heated box (55-60°C) so that arterialized blood could be obtained (1). The other cannula was placed in the contralateral arm so that 20% glucose could be infused via a variable-rate volumetric infusion pump (I-med, San Diego, CA).
After insertion of venous cannulas, a period of 90 min was allowed to elapse, followed by a 30-min basal period and a 90-min morning exercise period (EXE1), a 180-min resting period, and a second 90-min exercise period (EXE2; Fig. 1). Each exercise bout consisted of 90 min of continuous submaximal exercise (at 60-70 rpm) on an upright cycle ergometer (Medical Graphics, Yorba Linda, CA) at 80% of the individual's AT. Plasma glucose was maintained equivalent to basal levels throughout the study by a glucose-clamp technique, according to which glucose levels were measured every 5 min during both exercise periods and every 20 min during the rest interval between EXE1 and EXE2. A variable infusion of 20% dextrose was adjusted so that plasma glucose levels were held constant at the desired concentration (3). During the first 45 min after EXE1, a drink containing carbohydrate (1.5 g/kg body wt) was administered orally to replenish glycogen stores depleted during EXE1.
|
Analytic methods.
The collection and processing of blood samples have been described
elsewhere (11). Plasma glucose concentrations were
measured in triplicate using the glucose oxidase method with a glucose analyzer (Beckman, Fullerton, CA). Glucagon was measured according to a
modification of the method of Aguilar-Parada et al. (2), with an interassay coefficient of variation (CV) of 12%. Insulin was
measured as previously described (37), with an interassay CV of 9%. Catecholamines were determined by HPLC (10),
with an interassay CV of 12% for epinephrine and 8% for
norepinephrine. We made two modifications to the procedure for
catecholamine determination: 1) we used a five-point, rather
than a one-point, standard calibration curve, and 2) we
spiked the initial and final samples of plasma with known amounts of
epinephrine and norepinephrine so accurate identification of the
relevant respective catecholamine peaks could be made. Cortisol was
assayed using the Clinical Assays Gamma Coat RIA kit, with an
interassay CV of 6%. Growth hormone (GH) was determined by RIA
(28) using the Nichols Institute Diagnostics kit (San Juan
Capistrano, CA), with a CV of 8.6%. Pancreatic polypeptide was
measured by RIA using the method of Hagopian et al. (26),
with an interassay CV of 8%. Lactate, glycerol, alanine, and
-hydroxybutyrate were measured in deproteinized whole blood using
the method of Lloyd et al. (31). Nonesterified fatty acids
(FFA) were measured using the WAKO kit adapted for use on a centrifugal
analyzer (27).
Statistical analysis. Values are means ± SE unless otherwise stated and were analyzed using standard, parametric, two-way analysis of variance with repeated-measures design. When appropriate, Newman-Keuls post hoc test was performed to delineate at which time points statistical significance was reached. P < 0.05 indicated significant difference.
| |
RESULTS |
|---|
|
|
|---|
Plasma glucose and insulin levels. Plasma glucose was maintained at euglycemia throughout both episodes of exercise (morning baseline, 5.2 ± 0.1 mmol/l; EXE1 steady state, 5.2 ± 0.1 mmol/l; afternoon baseline, 5.0 ± 0.1 mmol/l; EXE2 steady state, 5.1 ± 0.1 mmol/l). Plasma insulin levels were similar at baseline (morning, 6.3 ± 0.8 µU/ml; afternoon, 8.8 ± 1.2 µU/ml) and during exercise steady state [last 30 min of exercise, 3.8 ± 0.7 (EXE1) and 4.7 ± 0.6 (EXE2) µU/ml]. No difference between genders was measured for glucose or insulin levels at any time during the study.
Counterregulatory hormone levels.
Baseline plasma epinephrine was 53 ± 9 pg/ml in the
morning and 37 ± 4 pg/ml in the afternoon (Fig.
2, Table
1). During both exercise bouts,
epinephrine increased similarly and significantly (P < 0.01) over basal values (
= 141 ± 32 and 161 ± 35 pg/ml during EXE1 and EXE2, respectively).
Baseline plasma norepinephrine was 315 ± 34 pg/ml in the morning
and 459 ± 45 pg/ml in the afternoon. During both exercise bouts,
norepinephrine increased significantly over basal values, but the
increase was blunted during EXE2 (
= 351 ± 92 pg/ml) compared with EXE1 (
= 597 ± 102 pg/ml, P < 0.05). When data were separated by gender,
in women the epinephrine response was increased in the afternoon,
whereas the norepinephrine response was unchanged. In men, both
catecholamine responses were reduced in the afternoon.
|
|
= 17 ± 4 and 17 ± 3 pg/ml, respectively), with no
difference between genders.
Basal levels of plasma cortisol (Table 1, Fig.
3) were 15 ± 2 µg/dl in the
morning and increased to 21 ± 2 µg/dl during EXE1. Although basal levels were lower in the afternoon than in the morning
(9 ± 1 µg/dl), the exercise-induced increments during both
bouts of exercise were identical (6 ± 2 µg/dl). The afternoon cortisol response to exercise was significantly greater than the morning response in women, while it was reduced in men.
|
Glucose infusion and substrate oxidation rates.
No exogenous glucose was infused at the time of morning baseline
measurements. During EXE1, exogenous glucose was gradually needed to maintain euglycemia, with an average infusion rate of 7 ± 2 µmol · kg
1 ·min
1
(9 ± 3 in men and 4 ± 2 in women) during the last 30 min of
exercise (Fig. 4). In the afternoon, the
basal glucose infusion rate was 6 ± 2 µmol · kg
1 · min
1 (8 ± 3 in men and 4 ± 2 in women) and progressively increased to 32 ± 4 µmol · kg
1 · min
1
(34 ± 8 in men and 30 ± 7 in women) during the last 30 min
of EXE2 (P < 0.001 vs. EXE1).
|
1 · min
1 (8 ± 1 in men and 8 ± 3 in women), and the rate of fat oxidation (FFAox) was 0.7 ± 0.2 mg · kg
1 · min
1 (0.7 ± 0.2 in men and 0.8 ± 0.2 in women). At the end of
EXE1, RER was 0.90 ± 0.01 (0.91 ± 0.02 in men
and 0.89 ± 0.01 in women), Carbox was 98 ± 8 µmol · kg
1 · min
1
(111 ± 15 in men and 86 ± 7 in women), and
FFAox was 3.1 ± 0.3 mg · kg
1 · min
1 (3.2 ± 0.4 in men and 2.9 ± 0.7 in women). During afternoon baseline measurements, RER was 0.92 ± 0.03 (0.89 ± 0.06 in men and
0.95 ± 0.03 in women), Carbox was 18 ± 3 µmol · kg
1 · min
1
(15 ± 5 in men and 21 ± 2 in women), and FFAox
was 0.3 ± 0.2 mg · kg
1 · min
1 (0.4 ± 0.3 in men and 0.2 ± 0.2 in women). At the end of
EXE2, RER was 0.90 ± 0.01 (0.90 ± 0.02 in men
and 0.90 ± 0.01 in women), Carbox was 94 ± 8 mg · kg
1 · min
1
(100 ± 19 in men and 89 ± 7 in women), and
FFAox was 3.3 ± 0.4 mg · kg
1 · min
1 (3.3 ± 0.7 in men and 3.2 ± 0.4 in women).
Intermediary metabolism.
In the morning during the first 30 min of EXE1, blood
lactate levels increased from the basal level of 1.1 ± 0.1 mmol/l
to a peak value of 2.9 ± 0.3 mmol/l and gradually decreased to
1.7 ± 0.2 mmol/l at the end of EXE1 (Fig. 4). Lactate
excursions were reduced during EXE2 (basal, 1.5 ± 0.1 mmol/l; 30-min peak, 2.1 ± 0.2 mmol/l; end exercise, 1.4 ± 0.1 mmol/l; P < 0.05 vs. EXE1). Blood
alanine levels (Table 2) increased
moderately over baseline during EXE1 and remained unchanged
during EXE2.
|
-hydroxybutyrate also tended to be
lower in the afternoon (54 ± 26 µmol/l) than in the morning (99 ± 22 µmol/l) and increased significantly more during
EXE2 (by 109 ± 27 µmol/l) than during
EXE1 (by 29 ± 10 µmol/l, P < 0.01;
Table 2).
Cardiovascular parameters.
Heart rate and systolic, diastolic, and mean arterial pressures were
similar at baseline in the morning and afternoon and increased
equivalently during both exercise bouts (Table
3).
|
| |
DISCUSSION |
|---|
|
|
|---|
This study has investigated the effects of moderate antecedent morning exercise on counterregulatory responses to subsequent afternoon exercise of comparable intensity and duration. Euglycemia was maintained during exercise, and carbohydrate utilization was equalized during both exercise bouts via oral administration of glucose (1.5 g/kg body wt) after morning exercise. Compared with morning exercise, an almost five-times-greater exogenous glucose infusion was needed during afternoon exercise to maintain euglycemia. Although the afternoon increase in this metabolic response was similar in both genders, concomitant neuroendocrine responses were altered according to a clear gender-specific pattern. In men, catecholamines, GH, pancreatic polypeptide, and cortisol were reduced; in women, these responses were unchanged or increased.
During physical exercise of moderate intensity, such as that performed
in this study, plasma glucose levels are maintained relatively stable
by an equilibrium between endogenous glucose production and glucose
utilization by the working muscle. In our study, Carbox was
virtually identical during morning and afternoon exercise (98 ± 9 and 94 ± 10 µmol · kg
1 · min
1,
respectively). The exogenous glucose infusion needed to maintain a
plasma glucose level of ~52 mmol/l, on the other hand, was 31 ± 4 µmol · kg
1 · min
1
during the last 30 min of the afternoon exercise, as opposed to only
6 ± 2 µmol · kg
1 · min
1 during
the earlier bout of exercise. Because of similar morning and afternoon
Carbox, it would therefore appear that the increased rate
of exogenous glucose infusion needed in the afternoon to maintain
euglycemia was the result of decreased endogenous glucose production.
Gender-related differences in counterregulatory responses to stress are being increasingly recognized. Women typically display reduced neuroendocrine and metabolic responses to hypoglycemia (14) and exercise (16), possibly reflecting a greater sensitivity to ANS drive (14). Furthermore, exercise responses may be influenced in women by the phase of their menstrual cycle: FFA responses have been reported to be lower, and GH responses higher, during the luteal phase than during the follicular phase (6). Our laboratory has previously demonstrated that, after antecedent stress, counterregulatory responses to hypoglycemia are significantly blunted in men and women, but the magnitude of the blunting is consistently less in women than in men (16, 17, 21). Consistent with these previous observations, in the present study, key counterregulatory responses in men, such as epinephrine, norepinephrine, glucagon, cortisol, and pancreatic polypeptide, were attenuated in the afternoon, compared with the morning, exercise (Figs. 2 and 3). These responses were either unchanged or increased in women, resulting in a statistically significant gender difference in the pattern of change of these parameters between morning and afternoon exercise. It is interesting that these gender differences in counterregulatory responses were not paralleled by proportional differences in exogenous glucose infusion. Although explanations for this discrepancy remain speculative, we believe that the acute increase in insulin sensitivity induced by prior exercise may have overridden differences in counterregulatory responses and resulted in similar metabolic effects.
The lower peak lactate levels observed with the afternoon than with the morning exercise may be due to residual vasodilation from morning exercise, favoring O2 delivery and glucose oxidation over glycolysis. Although different levels of glycogen stores may also have contributed to the reduced lactate levels during afternoon compared with morning exercise, we believe that the oral glucose load administered at the end of morning exercise minimized the impact of this variable.
Although absolute values of FFA concentrations differed considerably between genders (Table 2), lipolytic responses appeared to be similar during both exercise bouts in men and women. It would therefore appear that the antecedent bout of exercise in women resulted in an acceleration of peripheral FFA disposal and/or increased FFA reesterification. The mechanisms responsible for this observation, which may include gender-specific regional hypersensitivity to insulin at the adipocyte, remain speculative.
The secretion of some counterregulatory hormones is modulated by
circadian patterns. Cortisol levels, in particular, are normally high
in the morning and progressively decrease during the day. Raised levels
of cortisol (2- to 3-fold) do not have an effect on increasing
endogenous glucose production for
180 min during hypoglycemia-inducing stress, during which time glucagon and
epinephrine play the greatest counterregulatory role (13).
Our exercise bouts, on the other hand, lasted only 90 min. We therefore
believe that in our particular experimental setting the relatively
small circadian changes in basal cortisol secretion would have had a negligible effect on our findings.
The degree of depletion of the body's glycogen stores may alter
substrate metabolism during exercise. To replenish glycogen stores, at
the end of morning exercise, we administered an oral load of
carbohydrate calculated to equal the amount oxidized during morning
exercise. It could be argued, however, that a greater depletion of
glycogen stores was present at the start of afternoon exercise because
of continued glucose oxidation during the 3-h interval between exercise
bouts. We believe, however, that if any additional glycogen depletion
was present before afternoon exercise, it would have been of negligible
magnitude for the following reasons: 1) glycogen depletion
during morning exercise was less than estimated from
Carbox, inasmuch as hepatic gluconeogenesis would have
contributed toward endogenous glucose production (7); 2) additional glucose was infused during the last 30 min of
morning exercise (7 µmol · kg
1 · min
1) and
during the last 90 min of the rest period (6 µmol · kg
1 · min
1),
providing an additional ~10 g of carbohydrate; and 3)
gluconeogenesis probably also contributed 5-10 g of glucose during
the rest period, as previously observed in similar experimental
conditions by Maehlum et al. (32). Differences in the
degree of glycogen depletion may also have existed between genders.
Before afternoon exercise was started, Carbox was ~40%
higher in women than in men. Had this difference been present for most
of the interval between exercises, it may indicate that a smaller
portion of exogenous glucose was channeled toward glycogen
replenishment in women.
Direct comparison of our results with the work of other investigators
is confounded by marked differences in experimental design and subject
characteristics. Nevertheless, it is worth noting that, in several
previous studies investigating counterregulatory responses to repeated
bouts of exercise, neuroendocrine responses were unchanged or increased
during later bouts of exercise compared with earlier exercise. Kanaley
et al. (30) reported a progressive increase in GH
secretion during three 30-min bouts of exercise at 70% of peak
O2
(
O2 peak); Marliss et al.
(33) reported similar increases in glucagon and
catecholamines during two short bouts of exercise at 100%
O2 peak; Brenner et al.
(8) reported unchanged catecholamine, GH, and cortisol responses during two 30-min bouts of exercise at 50%
O2 peak, whereas Kaciuba-Uscilko et al.
(29) reported progressively increased catecholamines,
cortisol, GH, and glucagon during four consecutive 30-min exercise
bouts at 50%
O2 peak, separated by
30-min intervals. It should be noted that in these studies all subjects were men. Furthermore, in two of the above-mentioned studies (30, 33), the experimental workload was 70-100%
O2 peak. At these elevated workloads,
the ANS drive is very high, the increase in endogenous glucose
production is disproportionally more than the increase in glucose
utilization, and hyperglycemia occurs. This generates metabolic
circumstances completely different from those in our study. Independent
of the workload used, however, levels of circulating glucose in all the
above-mentioned studies were lower during later bouts of exercise.
Felig et al. (19) reported that, of 19 healthy men
exercising at 60-65%
O2 peak to
exhaustion, 7 experienced severe hypoglycemia (blood glucose <2.5
mmol/l). In this group of subjects, plasma epinephrine levels correlated with the degree of hypoglycemia, and in a control group the
increase in catecholamines was prevented by glucose administration that
maintained euglycemia. In the study by Kasciuba-Uscilko et al., which
used an exercise workload similar to that of our study, the greatest
increases in counterregulatory hormones were measured during the fourth
exercise bout, when blood glucose had dropped to 3.3 mmol/l from an
initial level of 4.6 mmol/l. We therefore believe that unless
euglycemia is carefully maintained, as in the present study, the
confounding effect of concomitant hypoglycemia prevents the
identification of counterregulatory responses induced by exercise per se.
One implication of our findings is that hypoglycemia would have occurred during the afternoon bout of exercise had exogenous glucose not been administered to our subjects. This could be of particular relevance for patients with diabetes, who suffer a high prevalence of exercise-associated hypoglycemia (18, 25). Although the mechanisms causing exercise-associated hypoglycemia are unclear, studies in healthy subjects indicate that acute counterregulatory failure induced by prior stress is likely to play a role (16, 21). Further studies are needed to ascertain whether these concepts also apply to patients with diabetes.
In summary, this study has demonstrated that one episode of prior moderate, prolonged morning exercise markedly increased the body's need for exogenous glucose to maintain euglycemia during subsequent, afternoon exercise. Compared with morning exercise responses, the epinephrine, norepinephrine, GH, pancreatic polypeptide, and cortisol responses were decreased in men, whereas in women these parameters were unchanged or increased.
We conclude that, in overnight-fasted healthy man, prior moderate prolonged exercise markedly impaired the ability to maintain euglycemia during subsequent, comparable same-day exercise. Neuroendocrine counterregulatory responses in women are resistant to the blunting effects of antecedent exercise relative to men.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Eric Allen and Pam Venson for expert technical assistance. We also appreciate the skill and help of the nurses of Vanderbilt General Clinical Research Center.
| |
FOOTNOTES |
|---|
This work is supported by a grant from the Juvenile Diabetes Foundation International, National Institutes of Health Grants R01 DK-45369, Diabetes Research and Training Center Grant 5P60-AM-20593, and Clinical Research Center Grant M01-RR-00095, and a Veterans Affairs/Juvenile Diabetes Foundation International Diabetes Research Center Grant.
Address for reprint requests and other correspondence: P. Galassetti, 712 PRB, Div. of Diabetes and Endocrinology, Vanderbilt University Medical School, Nashville, TN 37232-6303 (E-mail: pietro.galassetti{at}mcmail.vanderbilt.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 20 October 2000; accepted in final form 12 February 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Abumrad, NN,
Rabin D,
Diamond MC,
and
Lacy WW.
Use of a heated superficial hand vein as an alternative site for measurement of amino acid concentration and for the study of glucose and alanine kinetics in man.
Metabolism
30:
936-940,
1981[ISI][Medline].
2.
Aguilar-Parada, E,
Eisentraut AM,
and
Unger RH.
Pancreatic glucagon secretion in normal and diabetic subjects.
Am J Med Sci
257:
415-419,
1969[ISI][Medline].
3.
Amiel, SA,
Tamborlane WV,
Simonson DC,
and
Sherwin RS.
Defective glucose counterregulation after strict control of insulin-dependent diabetes mellitus.
N Engl J Med
316:
1376-1383,
1987[Abstract].
4.
Beaver, WL,
Wasserman K,
and
Whipp BJ.
A new method for detecting anaerobic threshold by gas exchange.
J Appl Physiol
60:
2020-2027,
1986
5.
Bolli, GB,
DeFeo P,
Perriello G,
De Cosmo S,
Ventura MM,
Campbell PJ,
Brunetti P,
and
Gerich JE.
Role of hepatic autoregulation in defense against hypoglycemia in humans.
J Clin Invest
75:
1623-1631,
1985.
6.
Bonen, A,
Haynes FJ,
Watson-Wright W,
Sopper MM,
Pierce GN,
Low MP,
and
Graham TE.
Effect of menstrual cycle on metabolic responses to exercise.
J Appl Physiol
55:
1506-1513,
1983
7.
Borghouts, LB,
and
Keizer HA.
Exercise and insulin sensitivity: a review.
Int J Sports Med
20:
1-12,
2000.
8.
Brenner, I,
Shek PN,
Zamecnik J,
and
Shephard RJ.
Stress hormones and the immunological responses to heat and exercise.
Int J Sports Med
19:
130-143,
1998[ISI][Medline].
9.
Brenner, I,
Zamecnik J,
Shek PN,
and
Shephard RJ.
The impact of heat exposure and repeated exercise on circulating stress hormones.
Eur J Appl Physiol Occup Physiol
76:
445-454,
1997[ISI][Medline].
10.
Causon, R,
Caruthers M,
and
Rodnight R.
Assay of plasma catecholamines by liquid chromatography with electrical detection.
Ann Biochem
116:
223-226,
1982.
11.
Cherrington, AD,
Lacy WW,
and
Chiasson JL.
Effect of glucagon on glucose production during insulin deficiency in the dog.
J Clin Invest
62:
664-667,
1978.
12.
Cryer, PE.
Glucose counterregulation in man.
Diabetes
30:
261-264,
1981[ISI][Medline].
13.
Davis, SN,
and
Cherrington AD.
The hormonal and metabolic responses to prolonged hypoglycemia.
J Lab Clin Med
121:
21-31,
1993[ISI][Medline].
14.
Davis, SN,
Cherrington AD,
Goldstein RE,
Jacobs J,
and
Price L.
Effects of insulin on the counterregulatory response to equivalent hypoglycemia in normal females.
Am J Physiol Endocrinol Metab
265:
E680-E689,
1993
15.
Davis, SN,
Galassetti P,
Wasserman DH,
and
Tate D.
Effect of gender on neuroendocrine and metabolic counterregulatory responses to exercise in normal man.
J Clin Endocrinol Metab
85:
224-230,
2000
16.
Davis, SN,
Galassetti P,
Wasserman DH,
and
Tate D.
Effects of antecedent hypoglycemia on subsequent counterregulatory responses to exercise.
Diabetes
49:
73-81,
2000[Abstract].
17.
Davis, SN,
Shavers C,
and
Costa F.
Gender-related differences in counterregulatory responses to antecedent hypoglycemia in normal humans.
J Clin Endocrinol Metab
85:
2148-2157,
2000
18.
DeFeo, P,
Bolli GB,
Perriello G,
De Cosmo S,
Compagnucci P,
Santeusanio F,
Brunetti P,
Gerich JE,
Motolese J,
and
Brunelti P.
The adrenergic contribution to glucose counterregulation in type I diabetes mellitus.
Diabetes
32:
887-893,
1983[Abstract].
19.
Felig, P,
Cherif A,
Minageref A,
and
Wahren J.
Hypoglycemia during prolonged exercise in man.
N Engl J Med
306:
895-900,
1982[Abstract].
20.
Frizzell, RT,
Hendrick GK,
Brown LL,
Lacy DB,
Donahue DP,
Carr RK,
Williams PE,
Parlow AF,
Stevenson RW,
and
Cherrington AD.
Stimulation of glucose production through hormone secretion and other mechanisms during insulin-induced hypoglycemia.
Diabetes
37:
1531-1541,
1998[Abstract].
21.
Galassetti, P,
Tate D,
Mann S,
Costa F,
Wasserman DH,
and
Davis SN.
Effect of antecedent exercise on counterregulatory responses to subsequent hypoglycemia (Abstract).
Diabetes
49:
A11,
2000.
22.
Galbo, H.
Hormonal and Metabolic Adaptation to Exercise. New York: Thieme, 1983, p. 1-116.
23.
Galbo, H.
Autonomic neuroendocrine responses to exercise.
Scand J Sports Med
8:
3-17,
1986.
24.
Galbo, H.
The hormonal response to exercise.
Diabetes Metab Rev
1:
385-408,
1986[Medline].
25.
Gerich, JE,
Langlois M,
Noacco C,
Karam J,
and
Forsham PH.
Lack of a glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic
-cell defect.
Science
182:
171-173,
1973
26.
Hagopian, W,
Lever E,
Cen D,
Emmounoud D,
Polonsky K,
Pugh W,
Moosa A,
and
Jaspan JB.
Predominance of renal and absence of hepatic metabolism of pancreatic polypeptide in the dog.
Am J Physiol Endocrinol Metab
245:
E171-E177,
1983
27.
Ho, RJ.
Radiochemical assay of long chain fatty acid using 63Ni as tracer.
Anal Biochem
26:
105-113,
1970.
28.
Hunter, W,
and
Greenwood F.
Preparation of 131I-labeled human growth hormone of high specific activity.
Nature
194:
495-496,
1962[Medline].
29.
Kaciuba-Uscilko, H,
Kruk B,
Szczpaczewska M,
Opaszowski B,
Stupnicka E,
Bicz B,
and
Nazar K.
Metabolic, body temperature and hormonal responses to repeated periods of prolonged cycle-ergometer exercise in men.
Eur J Appl Physiol
64:
26-31,
1992.
30.
Kanaley, JA,
Weltman JY,
Veldhuis JD,
Rogol AD,
Hartman ML,
and
Weltman A.
Human growth hormone response to repeated bouts of aerobic exercise.
J Appl Physiol
83:
1756-1761,
1997
31.
Lloyd, B,
Burrin J,
Smythe P,
and
Alberti KGMM
Enzymatic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate.
Clin Chem
24:
1724-1729,
1978
32.
Maehlum, S,
Felig P,
and
Wahren J.
Splanchnic glucose and muscle glycogen metabolism after glucose feeding during postexercise recovery.
Am J Physiol Endocrinol Metab Gastrointest Physiol
235:
E255-E260,
1978
33.
Marliss, EB,
Simantirakis E,
Miles PD,
Purdon C,
Gougeon R,
Field CJ,
Halter JB,
and
Vranic M.
Glucoregulatory and hormonal responses to repeated bouts of intense exercise in normal male subjects.
J Appl Physiol
71:
924-933,
1991
34.
McCarthy, DA,
McDonald I,
Grant M,
Marbut M,
Watling M,
Nicholson S,
Deeks JJ,
Wade AJ,
and
Perry JD.
Studies on the immediate and delayed leucocytosis elicited by brief (30-min) strenuous exercise.
Eur J Appl Physiol
64:
513-517,
1992.
35.
Wasserman, DH.
Control of glucose fluxes during exercise in the postabsorptive state.
In: Annual Review of Physiology. Palo Alto, CA: Annual Reviews, 1995, p. 191-218.
36.
Wasserman, K.
The anaerobic threshold measurement to evaluate exercise performance.
Am Rev Respir Dis
129:
535-540,
1984.
37.
Wide, L,
and
Porath J.
Radioimmunoassay of proteins with the use of Sephadex-coupled antibodies.
Biochim Biophys Acta
130:
257-260,
1966.
38.
Wideman, L,
Weltman JY,
Shah N,
Story S,
Veldhuis JD,
and
Weltman A.
Effect of gender on exercise-induced growth hormone release.
J Appl Physiol
87:
1154-1162,
1999
This article has been cited by other articles:
![]() |
K. A. Stokes, C. Tyler, and K. L. Gilbert The growth hormone response to repeated bouts of sprint exercise with and without suppression of lipolysis in men J Appl Physiol, March 1, 2008; 104(3): 724 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Galassetti, D. Tate, R. A. Neill, S. Morrey, and S. N. Davis Effect of Gender on Counterregulatory Responses to Euglycemic Exercise in Type 1 Diabetes J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5144 - 5150. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ronsen, T. Lea, R. Bahr, and B. K. Pedersen Enhanced plasma IL-6 and IL-1ra responses to repeated vs. single bouts of prolonged cycling in elite athletes J Appl Physiol, June 1, 2002; 92(6): 2547 - 2553. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |